Manufacturing

Jun 01, 2018
By BioPharm International Editors
FUJIFILM Diosynth Biotechnologies opens Cambridge, MA center to promote collaboration with biotech companies.
May 30, 2018
By BioPharm International Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 29, 2018
By BioPharm International Editors
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
May 29, 2018
By BioPharm International Editors
The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson’s blockbuster Remicade (infliximab).
May 25, 2018
By BioPharm International Editors
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
May 24, 2018
By BioPharm International Editors
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
May 23, 2018
By BioPharm International Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 23, 2018
By BioPharm International Editors
WuXi Biologics will build a biologics manufacturing facility in Singapore that will use both fed-batch and continuous perfusion-based single-use bioreactors.
May 22, 2018
By BioPharm International Editors
The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
May 17, 2018
By BioPharm International Editors
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
native1_300x100
lorem ipsum